US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 17.400
  • -0.500-2.79%
Close Dec 20 16:00 ET
  • 17.400
  • 0.0000.00%
Post 20:01 ET
4.11BMarket Cap64.44P/E (TTM)

ADMA Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
78.13%119.84M
78.29%107.19M
43.86%81.88M
67.59%258.22M
47.86%73.9M
63.73%67.28M
77.33%60.12M
95.56%56.91M
90.36%154.08M
89.45%49.98M
Operating revenue
78.13%119.84M
78.29%107.19M
43.86%81.88M
67.59%258.22M
47.86%73.9M
63.73%67.28M
77.33%60.12M
95.56%56.91M
90.36%154.08M
89.45%49.98M
Cost of revenue
41.19%60.18M
14.52%49.74M
5.86%42.77M
42.47%169.27M
19.59%42.82M
35.59%42.62M
66.18%43.43M
58.80%40.4M
48.95%118.82M
56.54%35.8M
Gross profit
141.99%59.66M
244.24%57.45M
136.83%39.11M
152.21%88.94M
119.27%31.09M
155.30%24.65M
114.82%16.69M
350.92%16.51M
2,906.39%35.27M
303.76%14.18M
Operating expense
25.38%20.02M
6.35%18.25M
-0.23%17.29M
-9.81%67.31M
-16.72%16.85M
-15.84%15.97M
1.29%17.16M
-6.23%17.33M
25.33%74.63M
21.15%20.24M
Selling and administrative expenses
26.04%18.56M
16.56%16.61M
7.77%15.64M
12.51%59.02M
11.80%15.54M
14.22%14.73M
19.03%14.25M
5.93%14.51M
22.29%52.46M
18.78%13.89M
Research and development costs
-30.87%412K
-60.09%560K
-47.37%450K
-8.69%3.3M
-58.49%446K
-42.80%596K
60.64%1.4M
36.99%855K
-0.88%3.61M
47.42%1.07M
Depreciation amortization depletion
-84.36%28K
-20.67%142K
7.82%193K
1.26%724K
4.77%187K
0.09%179K
0.09%179K
0.09%179K
0.00%715K
0.00%178.49K
-Depreciation and amortization
-84.36%28K
-20.67%142K
7.82%193K
1.26%724K
4.77%187K
0.09%179K
0.09%179K
0.09%179K
0.00%715K
0.00%178.49K
Other operating expenses
118.63%1.02M
-29.33%942K
-43.54%1.01M
-76.09%4.27M
-86.54%685K
-90.39%467K
-66.01%1.33M
-55.22%1.78M
45.19%17.84M
24.17%5.09M
Operating profit
356.40%39.64M
8,387.74%39.2M
2,784.01%21.82M
154.95%21.63M
334.93%14.23M
193.22%8.69M
94.84%-473K
94.51%-813K
32.56%-39.37M
54.07%-6.06M
Net non-operating interest income expense
52.59%-2.83M
43.35%-3.33M
43.10%-3.39M
-21.71%-23.41M
2.29%-5.6M
-7.21%-5.98M
-28.75%-5.89M
-77.27%-5.95M
-47.70%-19.23M
-73.07%-5.73M
Non-operating interest income
57.45%666K
8.45%449K
131.33%384K
3,493.33%1.62M
25,116.32%612K
5,745.77%423K
18,145.92%414K
402.00%166K
28.57%45K
-12.03%2.43K
Non-operating interest expense
-45.31%3.5M
-39.94%3.78M
-38.36%3.77M
29.81%25.03M
8.34%6.22M
14.65%6.4M
37.74%6.3M
80.43%6.12M
47.65%19.28M
73.00%5.74M
Other net income (expense)
61.38%-56K
-23.08%-16K
-29.63%-35K
-262.23%-26.46M
-5,883.60%-26.28M
-1,403.99%-145K
33.06%-13K
99.61%-27K
-2,798.81%-7.31M
-202.36%-439.12K
Special income (charges)
----
----
----
-292.41%-26.17M
----
----
----
----
---6.67M
---59
-Less:Other special charges
----
----
----
292.41%26.17M
----
----
----
----
--6.67M
--59
Other non- operating income (expenses)
61.38%-56K
-23.08%-16K
-29.63%-35K
54.80%-287K
77.00%-101K
-1,403.99%-145K
33.06%-13K
83.82%-27K
-151.98%-635K
-202.32%-439.06K
Income before tax
1,332.71%36.75M
662.72%35.85M
371.04%18.4M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Income tax
840K
3.79M
595K
0
0
0
Net income
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Net income continuous Operations
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Minority interest income
Net income attributable to the parent company
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
Basic earnings per share
1,400.00%0.15
566.67%0.14
366.67%0.08
60.61%-0.13
-33.33%-0.08
112.50%0.01
57.14%-0.03
76.92%-0.03
35.29%-0.33
33.33%-0.06
Diluted earnings per share
1,400.00%0.15
533.33%0.13
366.67%0.08
60.61%-0.13
-33.33%-0.08
112.50%0.01
57.14%-0.03
76.92%-0.03
35.29%-0.33
33.33%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 78.13%119.84M78.29%107.19M43.86%81.88M67.59%258.22M47.86%73.9M63.73%67.28M77.33%60.12M95.56%56.91M90.36%154.08M89.45%49.98M
Operating revenue 78.13%119.84M78.29%107.19M43.86%81.88M67.59%258.22M47.86%73.9M63.73%67.28M77.33%60.12M95.56%56.91M90.36%154.08M89.45%49.98M
Cost of revenue 41.19%60.18M14.52%49.74M5.86%42.77M42.47%169.27M19.59%42.82M35.59%42.62M66.18%43.43M58.80%40.4M48.95%118.82M56.54%35.8M
Gross profit 141.99%59.66M244.24%57.45M136.83%39.11M152.21%88.94M119.27%31.09M155.30%24.65M114.82%16.69M350.92%16.51M2,906.39%35.27M303.76%14.18M
Operating expense 25.38%20.02M6.35%18.25M-0.23%17.29M-9.81%67.31M-16.72%16.85M-15.84%15.97M1.29%17.16M-6.23%17.33M25.33%74.63M21.15%20.24M
Selling and administrative expenses 26.04%18.56M16.56%16.61M7.77%15.64M12.51%59.02M11.80%15.54M14.22%14.73M19.03%14.25M5.93%14.51M22.29%52.46M18.78%13.89M
Research and development costs -30.87%412K-60.09%560K-47.37%450K-8.69%3.3M-58.49%446K-42.80%596K60.64%1.4M36.99%855K-0.88%3.61M47.42%1.07M
Depreciation amortization depletion -84.36%28K-20.67%142K7.82%193K1.26%724K4.77%187K0.09%179K0.09%179K0.09%179K0.00%715K0.00%178.49K
-Depreciation and amortization -84.36%28K-20.67%142K7.82%193K1.26%724K4.77%187K0.09%179K0.09%179K0.09%179K0.00%715K0.00%178.49K
Other operating expenses 118.63%1.02M-29.33%942K-43.54%1.01M-76.09%4.27M-86.54%685K-90.39%467K-66.01%1.33M-55.22%1.78M45.19%17.84M24.17%5.09M
Operating profit 356.40%39.64M8,387.74%39.2M2,784.01%21.82M154.95%21.63M334.93%14.23M193.22%8.69M94.84%-473K94.51%-813K32.56%-39.37M54.07%-6.06M
Net non-operating interest income expense 52.59%-2.83M43.35%-3.33M43.10%-3.39M-21.71%-23.41M2.29%-5.6M-7.21%-5.98M-28.75%-5.89M-77.27%-5.95M-47.70%-19.23M-73.07%-5.73M
Non-operating interest income 57.45%666K8.45%449K131.33%384K3,493.33%1.62M25,116.32%612K5,745.77%423K18,145.92%414K402.00%166K28.57%45K-12.03%2.43K
Non-operating interest expense -45.31%3.5M-39.94%3.78M-38.36%3.77M29.81%25.03M8.34%6.22M14.65%6.4M37.74%6.3M80.43%6.12M47.65%19.28M73.00%5.74M
Other net income (expense) 61.38%-56K-23.08%-16K-29.63%-35K-262.23%-26.46M-5,883.60%-26.28M-1,403.99%-145K33.06%-13K99.61%-27K-2,798.81%-7.31M-202.36%-439.12K
Special income (charges) -------------292.41%-26.17M-------------------6.67M---59
-Less:Other special charges ------------292.41%26.17M------------------6.67M--59
Other non- operating income (expenses) 61.38%-56K-23.08%-16K-29.63%-35K54.80%-287K77.00%-101K-1,403.99%-145K33.06%-13K83.82%-27K-151.98%-635K-202.32%-439.06K
Income before tax 1,332.71%36.75M662.72%35.85M371.04%18.4M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Income tax 840K3.79M595K000
Net income 1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Net income continuous Operations 1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Minority interest income
Net income attributable to the parent company 1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M
Basic earnings per share 1,400.00%0.15566.67%0.14366.67%0.0860.61%-0.13-33.33%-0.08112.50%0.0157.14%-0.0376.92%-0.0335.29%-0.3333.33%-0.06
Diluted earnings per share 1,400.00%0.15533.33%0.13366.67%0.0860.61%-0.13-33.33%-0.08112.50%0.0157.14%-0.0376.92%-0.0335.29%-0.3333.33%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List